Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$13.56
-8.54%
Mkt Cap $4.49K
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
Implied Upside
+121.3%
Consensus $30.00 vs current $13.56
NASDAQ·Healthcare·Biotechnology
$13.56
-8.54%
Mkt Cap $4.49K
No recent rating data.
Price Target (1 analysts)
$30.00
Range $30.00 – $30.00
+121.3%
Consensus $30.00 vs current $13.56